These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6689310)
1. [Sucralfate (Ulcogant). Mechanism of action of a cytoprotective agent]. Steiner KF Fortschr Med; 1983 Dec; 101(46):2153-6 contd. PubMed ID: 6689310 [No Abstract] [Full Text] [Related]
2. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent. McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973 [TBL] [Abstract][Full Text] [Related]
3. [Sucralfate]. Muñoz Navas M; Sánchez L; Zozaya JM; Conchillo F Rev Med Univ Navarra; 1984 Jun; 28(2):61-2. PubMed ID: 6548576 [No Abstract] [Full Text] [Related]
5. [Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties]. Gorget C Rev Med Interne; 1985 Jun; 6(3):313-9. PubMed ID: 3901171 [TBL] [Abstract][Full Text] [Related]
6. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals. Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647 [TBL] [Abstract][Full Text] [Related]
7. Development and characteristics of sucralfate. Nagashima R J Clin Gastroenterol; 1981; 3(Suppl 2):103-10. PubMed ID: 6798099 [TBL] [Abstract][Full Text] [Related]
8. [Sucralfate (Ulcogant). The mechanism of action of a cytoprotective agent]. Steiner KF Fortschr Med; 1983 Dec; 101(47-48):2197-200concl. PubMed ID: 6423500 [TBL] [Abstract][Full Text] [Related]
9. [Sucralfate protects the ulcer from acids and pepsin]. von Bocko Polach U Med Klin; 1980 Oct; 75(21):764-7. PubMed ID: 6779100 [No Abstract] [Full Text] [Related]
10. Pharmacology, clinical efficacy, and adverse effects of sucralfate, a nonsystemic agent for peptic ulcer. Spiro HM Pharmacotherapy; 1982; 2(2):67-71. PubMed ID: 6927335 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of peptic activity by sucralfate. Samloff IM; O'Dell C Am J Med; 1985 Aug; 79(2C):15-8. PubMed ID: 3929601 [TBL] [Abstract][Full Text] [Related]
12. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. Giesing DH; Bighley LD; Iles RL J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of action of sucralfate. Nagashima R J Clin Gastroenterol; 1981; 3(Suppl 2):117-27. PubMed ID: 6798100 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater. Samloff IM Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806 [TBL] [Abstract][Full Text] [Related]
16. Sucralfate in the treatment of peptic ulcer. Denyer ME Practitioner; 1983 Apr; 227(1378):633-4. PubMed ID: 6344058 [No Abstract] [Full Text] [Related]
17. Third International Sucralfate Symposium. Peptic ulcer disease and gastritis: a worldwide review. September 17, 1984, Lisbon, Portugal. Am J Med; 1985 Aug; 79(2C):1-64. PubMed ID: 3839971 [No Abstract] [Full Text] [Related]
18. Sucralfate for peptic ulcer. Drug Ther Bull; 1983 Sep; 21(18):69-70. PubMed ID: 6354660 [No Abstract] [Full Text] [Related]
20. Sucralfate, a basic aluminum salt of sucrose sulfate. I. Behaviors in gastroduodenal pH. Nagashima R; Yoshida N Arzneimittelforschung; 1979; 29(11):1668-76. PubMed ID: 44471 [No Abstract] [Full Text] [Related] [Next] [New Search]